Ardent Health Corporation Securities Fraud Class Action Result of Undisclosed Financial Problems and 33% Stock Decline - Investors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC
Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors with substantial losses that they have until March 9, 2026 to file lead plaintiff applications in a securities class action lawsuit against Ardent Health, Inc. (“Ardent” or the “Company”) (
NYSE: ARDT), if they purchased or otherwise acquired the Company’s securities between July 18, 2024 and November 12, 2025, inclusive (the “Class Period”). This action is pending in the United States District Court for the Middle District of Tennessee.
ARDT ALERT: Kirby McInerney LLP Announces the Filing of a Securities Class Action on Behalf of Ardent Health, Inc. Investors
The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed on behalf of investors who acquired Ardent Health, Inc. (“Ardent” or the “Company”) (
NYSE:ARDT) securities during the period of July 18, 2024 through November 12, 2025, inclusive (“the Class Period”).
Securities Fraud Investigation Into Ardent Health, Inc. (ARDT) Announced – Investors Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz
The Law Offices of Frank R. Cruz announces an investigation of Ardent Health, Inc. (“Ardent” or the “Company”) (
NYSE: ARDT) on behalf of investors concerning the Company’s possible violations of federal securities laws.
Rosen Law Firm Urges Ardent Health, Inc. (NYSE: ARDT) Stockholders to Contact the Firm for Information About Their Rights
Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers of securities of Ardent Health, Inc. (
NYSE: ARDT) between July 18, 2024 and November 12, 2025. Ardent Health describes itself as a company that “operates acute care hospitals and other healthcare facilities.”
ARDT INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Announces that Ardent Health, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Ardent Health, Inc. (
NYSE: ARDT) securities between July 18, 2024 and November 12, 2025, inclusive (the “Class Period”), have until March 9, 2026 to seek appointment as lead plaintiff of the Ardent Health class action lawsuit. Captioned Postiwala v. Ardent Health, Inc., No. 26-cv-00022 (M.D. Tenn.), the Ardent Health class action lawsuit charges Ardent Health and certain of Ardent Health’s top executives with violations of the Securities Exchange Act of 1934.
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Ardent Health
Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Ardent Health, Inc. (“Ardent” or the “Company”) (
NYSE: ARDT) and reminds investors of the March 9, 2026 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.
ARDENT HEALTH ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Ardent Health, Inc. and Encourages Investors to Contact the FirmBragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Ardent Health (ARDT) To Contact Him Directly To Discuss Their Options
Investor Notice: Robbins LLP Informs Investors of the Ardent Health, Inc. Securities Class Action
Robbins LLP informs stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Ardent Health, Inc. (
NYSE: ARDT) securities between July 18, 2025 and November 12, 2025. Ardent Health and its affiliates operate acute care hospitals and other healthcare facilities.
ARDT BREAKING CLASS ACTION NEWS: BFA Law has Sued Ardent Health, Inc. for Securities Fraud after Collectability Issues lead to 33% Stock Drop -- Investors Notified to Contact the Firm
Leading securities law firm Bleichmar Fonti & Auld LLP announces that it has filed a class action lawsuit against Ardent Health, Inc. (
NYSE:ARDT) and certain of the Company’s senior executives for securities fraud after a significant stock drop resulting from potential violations of the federal securities laws.
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Ardent Health, Inc. - ARDTNEW YORK, Jan. 06, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Ardent Health, Inc. (“Ardent” or the “Company”) (
NYSE: ARDT). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.
ARDT Investigation: Investors Encouraged to Contact Kirby McInerney LLP
The law firm of Kirby McInerney LLP reminds investors its investigation on behalf of Ardent Health, Inc. (“Ardent” or the “Company”) (
NYSE:ARDT) investors concerning the Company's and/or members of its senior management’s possible violation of the federal securities laws or other unlawful business practices.
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Ardent Health, Inc. - ARDTNEW YORK, Dec. 30, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Ardent Health, Inc. (“Ardent” or the “Company”) (
NYSE: ARDT). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.
ARDT INVESTIGATION ALERT: Robbins Geller Rudman & Dowd LLP Launches Investigation Into Ardent Health, Inc. and Encourages Investors and Potential Witnesses to Contact Law Firm
The law firm of Robbins Geller Rudman & Dowd LLP is investigating potential violations of U.S. federal securities laws involving Ardent Health, Inc. (
NYSE: ARDT), focused on whether Ardent Health and certain of its top executives made false and/or misleading statements and/or failed to disclose material information to investors.
ARDT Investors Have Opportunity to Join Ardent Health, Inc. Fraud Investigation with the Schall Law FirmLOS ANGELES, Dec. 10, 2025 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Ardent Health, Inc. (“Ardent” or “the Company”) (
NYSE: ARDT) for violations of the securities laws.
ARDT Investors Have Opportunity to Join Ardent Health, Inc. Fraud Investigation with the Schall Law FirmLOS ANGELES, Dec. 03, 2025 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Ardent Health, Inc. (“Ardent” or “the Company”) (
NYSE: ARDT) for violations of the securities laws.
ARDT Investors Have Opportunity to Join Ardent Health, Inc. Fraud Investigation with the Schall Law FirmLOS ANGELES, Nov. 26, 2025 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Ardent Health, Inc. (“Ardent” or “the Company”) (
NYSE: ARDT) for violations of the securities laws.
ARDT Investors Have Opportunity to Join Ardent Health, Inc. Fraud Investigation with the Schall Law FirmLOS ANGELES, Nov. 19, 2025 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Ardent Health, Inc. (“Ardent” or “the Company”) (
NYSE: ARDT) for violations of the securities laws.
ARDT Investors Have Opportunity to Join Ardent Health, Inc. Fraud Investigation with the Schall Law Firm
The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Ardent Health, Inc. (“Ardent” or “the Company”) (
NYSE: ARDT) for violations of the securities laws.
ARDENT ALERT: Bragar Eagel & Squire, P.C. is Investigating Ardent Health, Inc. on Behalf of Ardent Stockholders and Encourages Investors to Contact the FirmBragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Ardent (ARDT) To Contact Him Directly To Discuss Their Options
Ardent Health Announces $50 Million Share Repurchase Program Authorization
Ardent Health (
NYSE: ARDT), a leading provider of healthcare in growing mid-sized urban communities across the U.S., today announced its Board of Directors has authorized a share repurchase program of up to $50 million.
Ardent Health, Inc. (ARDT) Under Investigation After Shares Plummet Over 33%
Shares of Ardent Health, Inc. (“Ardent Health”) plummeted over 33% in intraday trading on November 13, 2025, after the company reported a $43 million decrease in revenue following recent “hindsight evaluations of historical collection trends,” along with a $54 million rise in its professional liability reserves. Gibbs Mura is investigating a potential Ardent Health, Inc. (
NYSE: ARDT) Securities Class Action Lawsuit for investors over the company’s possible violations of federal securities laws.
ARDT BREAKING: Ardent Health, Inc. Revenue Drop Triggers Securities Fraud Investigation after Stock Plummets 33% -- Investors Urged to Contact BFA Law
Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into Ardent Health, Inc. (
NYSE: ARDT) for potential violations of the federal securities laws.
Ardent Health Reports Third Quarter 2025 Results
Ardent Health, Inc. (
NYSE: ARDT) ("Ardent Health" or the "Company"), a leading provider of healthcare in growing mid-sized urban communities across the U.S., today announced results for the quarter ended September 30, 2025.
Ardent Health to Participate in the 2025 Stephens Annual Investment Conference
Ardent Health (
NYSE: ARDT), a leading provider of healthcare in growing mid-sized urban communities across the U.S., today announced that the Company will participate in the 2025 Stephens Annual Investment Conference on Tuesday, Nov. 18, 2025, in Nashville, Tennessee.
